MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

Home・Stock List・Celldex Therapeutics Inc

Celldex Therapeutics Inc

Closed

SectorHealthcare

27.15 1.76

Buy Sell

Overview

Share price change

24h

Current

Min

25.38

Max

27.34

Key metrics
By Trading Economics
Income	-2.8M -57M
Sales	35K 730K
Profit margin	-7,753.425
Employees	186
EBITDA	-1.1M -63M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+84.27% upside

Dividends
By Dow Jones
Next Earnings	4 Nov 2025

Market Stats
By TradingEconomics
Market Cap	304M 1.8B
Previous open	25.39
Previous close	27.15

News Sentiment

By Acuity

21%

79%

35 / 371 Healthcare

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

18.91 / 20.63 Support & Resistance

Celldex Therapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

12 Oct 2025, 21:50 UTC

Acquisitions, Mergers, Takeovers

Caterpillar to Acquire Australia's RPM Global for $730 Million

10 Oct 2025, 21:38 UTC

Acquisitions, Mergers, Takeovers

Strathcona Resources Terminates Take-Over Bid for MEG Energy

12 Oct 2025, 23:47 UTC

Market Talk

Gold Rises, Buoyed by Monetary Debasement Fears -- Market Talk

12 Oct 2025, 23:39 UTC

Market Talk

Oil Rises on Likely Technical Recovery, Mildly Positive Sentiment -- Market Talk

12 Oct 2025, 23:22 UTC

Market Talk

New Zealand Braces For Renewed Trade War Uncertainty -- Market Talk

12 Oct 2025, 23:16 UTC

Acquisitions, Mergers, Takeovers

Caterpillar Inc. Enters Into Agreement To Acquire RPMGlobal >CAT RUL.AU

12 Oct 2025, 22:32 UTC

Market Talk

Copper, U.S. Thermal Coal Stand Out as Metals Ride Macro Tailwinds -- Market Talk

12 Oct 2025, 21:28 UTC

Acquisitions, Mergers, Takeovers

RPM Global Says Board Unanimously Recommends Shareholders Accept Caterpillar Offer

12 Oct 2025, 21:28 UTC

Acquisitions, Mergers, Takeovers

RPM Global Agrees to Takeover by Caterpillar

12 Oct 2025, 21:28 UTC

Acquisitions, Mergers, Takeovers

RPM Global Says Caterpillar Offering A$5.00/Share in Cash

11 Oct 2025, 08:20 UTC

Market Talk

Financial Services Roundup: Market Talk

11 Oct 2025, 00:18 UTC

Acquisitions, Mergers, Takeovers

Why Biotech May Be Back -- Barrons.com

10 Oct 2025, 21:07 UTC

Earnings

Acquisitions, Mergers, Takeovers

Dell Is Just Beginning to Tell Its AI Story. Buy the Stock. -- Barrons.com

10 Oct 2025, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

10 Oct 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

10 Oct 2025, 20:50 UTC

Market Talk

Acquisitions, Mergers, Takeovers

Health Care Roundup: Market Talk

10 Oct 2025, 20:06 UTC

Market Talk

Fed Won't Publish Monthly Industrial Data Next Week -- Market Talk

10 Oct 2025, 20:06 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

10 Oct 2025, 19:56 UTC

Market Talk

U.S.-China Tension Weighs Down on Treasury Yields, Dollar -- Market Talk

10 Oct 2025, 19:20 UTC

Market Talk

Oil Futures Sink As Trump Rekindles Trade Tensions -- Market Talk

10 Oct 2025, 19:02 UTC

Market Talk

U.S. Natural Gas Futures Post Weekly Loss -- Market Talk

10 Oct 2025, 18:58 UTC

Market Talk

Canada's Jobs Gain Marks a 'Head Fake' For Economy -- Market Talk

10 Oct 2025, 18:52 UTC

Market Talk

PepsiCo Lays Groundwork for Improvement -- Market Talk

10 Oct 2025, 18:47 UTC

Market Talk

Precious Metals Turn Higher After Profit-Taking Slide -- Market Talk

10 Oct 2025, 18:35 UTC

Market Talk

Canada's Next Rate Cut May be Pushed to December -- Market Talk

10 Oct 2025, 18:31 UTC

Market Talk

Canada's Labor Market Firming. But Conditions Vary Across Country -- Market Talk

10 Oct 2025, 17:32 UTC

Market Talk

U.S. Oil Rig Count Declines by Four to 418 -- Market Talk

10 Oct 2025, 16:55 UTC

Earnings

These Stocks Are Moving the Most Today: MP Materials, Nvidia, Alibaba, Venture Global, Applied Digital, Qualcomm, and More -- Barrons.com

10 Oct 2025, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

10 Oct 2025, 16:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

Peer Comparison

Price change

Celldex Therapeutics Inc Forecast

Price Target

By TipRanks

84.27% upside

12 Months Forecast

Average 49.33 USD 84.27%

High 67 USD

Low 25 USD

Based on 11 Wall Street analysts offering 12 month price targets forCelldex Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

11 ratings

Buy

Hold

Sell

Based on 11 analysts giving stock ratings to Celldex Therapeutics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

18.91 / 20.63Support & Resistance

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

35 / 371 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Celldex Therapeutics Inc

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory, allergic, autoimmune, and other devastating diseases. The company's clinical development programs CDX-0159, a Phase II monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity. It has research collaboration and license agreements with Yale University. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey.